Indegene Limited

NSE:INDGN.NS

Location

Market Cap

USD 1.60 B

Share Price

USD 6.67

Avg Daily Volume

1,225,236

Change (1 day)

0.65%

Change (1 year)

-1.83%

Change (YTD)

-5.37%

Indegene Limited Operating Income Margin for the year ending March 31, 2025: 36.07%

Indegene Limited Operating Income Margin is 36.07% for the year ending March 31, 2025, a 6.77% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2024 was 33.78%, a 105.30% change year over year.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2024 was 33.78%, a 0.00% change year over year.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2023 was 16.45%, a 0.13% change year over year.
  • Indegene Limited Operating Income Margin for the year ending March 31, 2022 was 16.43%, a -29.66% change year over year.
Key data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin
Market news
Loading...
NSE: INDGN.NS

Indegene Limited

CEO Mr. Manish Gupta
IPO Date May 13, 2024
Location India
Headquarters Manyata Embassy Business Park
Employees 4,367
Sector 🏥 Health Care
Industries
Description

Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The company was incorporated in 1998 and is based in Bengaluru, India.

Similar companies

ABBV

AbbVie Inc.

USD 183.76

-0.83%

NOVO-B.CO

Novo Nordisk A/S

USD 69.76

-4.86%

RO.SW

Roche Holding AG

USD 339.66

0.85%

ABT

Abbott Laboratories

USD 133.26

0.20%

NOVN.SW

Novartis AG

USD 116.67

0.62%

AZN.L

AstraZeneca PLC

USD 140.89

0.81%

MRK

Merck & Co., Inc.

USD 80.16

1.39%

AMGN

Amgen Inc.

USD 272.44

-5.84%

PFE

Pfizer Inc.

USD 24.03

0.25%

GILD

Gilead Sciences, Inc.

USD 106.19

-2.13%

SAN.PA

Sanofi

USD 96.16

0.29%

VRTX

Vertex Pharmaceuticals Incorporated

USD 443.54

0.61%

BMY

Bristol-Myers Squibb Company

USD 46.92

0.13%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 51.71

0.69%

GSK.L

GSK plc

USD 18.97

0.58%

CSL.AX

CSL Limited

USD 156.77

0.82%

ZTS

Zoetis Inc.

USD 157.34

0.11%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 126.58

-0.39%

REGN

Regeneron Pharmaceuticals, Inc.

USD 511.92

0.43%

LONN.SW

Lonza Group AG

USD 688.40

0.56%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

0.15%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.87

1.96%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 313.13

1.11%

UCB.BR

UCB SA

USD 190.31

4.88%

GEHC

GE HealthCare Technologies Inc.

USD 71.16

-0.17%

BAYN.DE

Bayer AG

USD 30.38

-1.22%

068270.KS

Celltrion, Inc.

USD 118.44

2.18%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.70

2.46%

SDZ.SW

Sandoz Group AG

USD 52.94

-0.71%

LH

Laboratory Corporation of America Holdings

USD 261.04

-0.32%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.73

2.31%

RPRX

Royalty Pharma plc

USD 35.40

1.55%

INSM

Insmed Incorporated

USD 105.42

2.67%

RGC

Regencell Bioscience Holdings Limited

USD 23.70

-37.65%

BIIB

Biogen Inc.

USD 124.76

-1.80%

4503.T

Astellas Pharma Inc.

USD 9.54

2.70%

1801.HK

Innovent Biologics, Inc.

USD 10.23

1.81%

SMMT

Summit Therapeutics Inc.

USD 20.39

-0.83%

4507.T

Shionogi & Co., Ltd.

USD 17.49

1.37%

GMAB.CO

Genmab A/S

USD 209.44

-1.30%

NBIX

Neurocrine Biosciences, Inc.

USD 125.80

-0.59%

2269.HK

WuXi Biologics (Cayman) Inc.

USD 3.22

3.10%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 36.76

0.26%

TEM

Tempus AI, Inc.

USD 65.65

-3.89%

MANKIND.NS

Mankind Pharma Limited

USD 26.77

0.47%

EXEL

Exelixis, Inc.

USD 43.37

7.43%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.75

0.99%

ASND

Ascendis Pharma A/S

USD 175.78

-0.63%

BMRN

BioMarin Pharmaceutical Inc.

USD 54.08

-1.67%

StockViz Staff

June 25, 2025

Any question? Send us an email